{
    "news": [
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Trump imposes tariffs on Chinese imports as Canada, Mexico spared. Will EU be next? President's victory plan unclear.",
            "id": "f58f8ee7-6e81-4f52-ac1d-1e527ff1aba5",
            "is_major": true,
            "source": "NYT",
            "source_type": "news",
            "summary": "The latest round of tariffs on Chinese imports has been implemented, raising concerns about possible additional tariffs on the European Union. Despite this, Canada and Mexico have been granted a temporary exemption. The President's stance on victory amidst the trade tensions remains unclear.",
            "tickers": [],
            "time": "12:45:21",
            "timestamp": "2025-02-04T12:45:21Z",
            "url": "https://www.nytimes.com/2025/02/04/business/dealbook/trump-trade-china-european-union.html"
        },
        {
            "beta_headline": null,
            "category": "commodities",
            "date": "2025-02-04",
            "headline": "\"US Oil Refining Industry Outlook 2025-2030: Forecasts production, consumption, refinery capacities, and major companies.\"",
            "id": "67aa68f0-331f-4df1-bf04-2865f4618b17",
            "is_major": false,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "A report titled \"Oil Refining Industry in the United States 2025\" has been included in ResearchAndMarkets.com's catalog. This comprehensive report offers detailed insights into the crude oil refining industry in the United States. It covers information at the refinery level, including current and future (new build) facilities. The report includes forecasts and insights on refinery capacities, production and consumption of refined petroleum products, refinery complexity factors, and peer comparisons. This resource serves as a valuable reference for industry professionals seeking in-depth analysis.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:36:22",
            "timestamp": "2025-02-04T12:36:22Z",
            "url": "http://www.businesswire.com/news/home/20250204595003/en/United-States-Oil-Refining-Industry-Outlook-2025-2030-Forecasts-of-Refined-Products-Production-and-Consumption-with-Major-Refining-Companies-and-Operators---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-YKT6SDyMw5Lye4ovXwHmkqD8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5idAXrgr_e1ZUbxvK6BY66Xm"
        },
        {
            "beta_headline": null,
            "category": "commodities",
            "date": "2025-02-04",
            "headline": "Report on India Oil Refining Industry until 2025, providing data on planned refineries' capacities, costs, operators, and commissioning dates - ResearchAndMarkets.com.",
            "id": "41f42879-d29b-409a-83ea-4c7e1eec9a90",
            "is_major": false,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "A comprehensive report titled \"Oil Refining Industry in India 2025\" has recently been included in ResearchAndMarkets.com's listings. The report offers detailed insights into India's crude oil refining sector, encompassing data on current operational refineries and those in the planning stage. It presents valuable information on refinery capacities, production and consumption of refined petroleum products, refinery complexity factor, and a comparative analysis with similar countries. This report serves as a vital resource for those seeking in-depth knowledge of the Indian oil refining industry.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:36:20",
            "timestamp": "2025-02-04T12:36:20Z",
            "url": "http://www.businesswire.com/news/home/20250204725854/en/India-Oil-Refining-Industry-Report-2025-Data-on-Planned-Refineries-such-as-Planned-Capacity-Equity-Structure-Operator-Company-Expected-Commissioning-Date-and-Project-Cost---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-YKT6SDyMw5Lye4ovXwHmkqD8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5idAXrgr_e1ZUbxvK6BY66Xm"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Lancaster Colony Corp's Q2 sales reach record $509.3 million, a 4.8% increase. Retail sales at $280.8 million, Foodservice at $228.5 million.",
            "id": "c6f798b9-ca35-45ca-b2a6-ef4cea50fcff",
            "is_major": true,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "Westerville, Ohio-based Lancaster Colony Corporation (Nasdaq: LANC) released its fiscal second quarter results for the period ending December 31, 2024. Total consolidated net sales saw a 4.8% increase, reaching a record high of $509.3 million compared to $485.9 million in the previous year. Retail net sales also experienced growth, rising by 6.3% to $280.8 million, while Foodservice net sales advanced by 3.0% to $228.5 million. Additionally, consolidated gross profit saw a substantial increase of $11.3 million, marking a 9.3% rise to a record $132.8 million.",
            "tickers": [
                "LANC",
                "NDXP"
            ],
            "time": "12:36:16",
            "timestamp": "2025-02-04T12:36:16Z",
            "url": "http://www.businesswire.com/news/home/20250203427227/en/Lancaster-Colony-Reports-Second-Quarter-Sales-and-Earnings/?feedref=JjAwJuNHiystnCoBq_hl-fLcmYSZsqlD_XPbplM8Ta6D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5iej_DoWrIhfD31cAxcB60aE"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Nabis partners with Dutchie and Embarc to standardize cannabis wholesaling, driving supply chain innovation.",
            "id": "8d1d9fec-ff0e-4575-95a1-c5d67d052a58",
            "is_major": true,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "In San Francisco, Nabis, a prominent licensed wholesale platform for the cannabis sector, has unveiled a significant advancement in cannabis supply chain operations by incorporating retail partnerships into their extensive network. This milestone introduction includes two key collaborations: a partnership with Dutchie, the leading point-of-sale platform in the industry, to integrate technology; and a distribution arrangement with Embarc, a well-known California-based brand.",
            "tickers": [
                "SAN",
                "NDXP"
            ],
            "time": "12:36:11",
            "timestamp": "2025-02-04T12:36:11Z",
            "url": "http://www.businesswire.com/news/home/20250204693059/en/Nabis-Expands-Offerings-to-Retailers-Driving-Cannabis-Wholesaling-Standardization-with-Tech-and-Logistics/?feedref=JjAwJuNHiystnCoBq_hl-ZzpnHS32O5tBfLZHwy8L1lVsKLHj4l7ufu4XoarznHcCc3RCn2ioKmwBZbtUT_laxlCBS-6lALTzeuzMorsqlUBRXBIbEfS-L7bFkq7lPbqxuv9GxLR3d-mCpNfrf5FyQ=="
        },
        {
            "beta_headline": null,
            "category": "investing",
            "date": "2025-02-04",
            "headline": "UK to host UK-EU leaders\u2019 summit on May 19th.",
            "id": "79c80e22-0384-41c5-af39-97d9e479a95f",
            "is_major": true,
            "source": "Tradex",
            "source_type": "news",
            "summary": null,
            "tickers": [],
            "time": "12:35:38",
            "timestamp": "2025-02-04T12:35:38Z",
            "url": null
        },
        {
            "beta_headline": null,
            "category": "crypto",
            "date": "2025-02-04",
            "headline": "Trump meme coin (CRYPTO: TRUMP) plunges 42.6% due to tariff announcement. Whale suffers $21 million loss after reinvesting $11.8 million profit.",
            "id": "c042f2ae-c11d-4f52-ae2c-7e44cb11e345",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The meme coin Trump (CRYPTO: TRUMP) saw a significant decline of 42.6% in the last week after an announcement by Donald Trump regarding tariffs. A prominent whale in the crypto space obtained $11.8 million in TRUMP profits in mid-January and reinvested the amount, ultimately facing a loss. This whale invested $33.9 million to buy 766,083 TRUMP at an average price of $44.25, resulting in a $21 million loss due to the decline in prices. Consequently, not only did they lose their entire profit, but also $9 million of their original capital. The drop has been substantial despite more data available on the matter.",
            "tickers": [],
            "time": "12:34:13",
            "timestamp": "2025-02-04T12:34:13Z",
            "url": "https://www.benzinga.com/markets/cryptocurrency/25/02/43459125/trump-meme-coin-down-42-in-a-week-how-low-can-it-go"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Alan Roura to participate in his third Vend\u00e9e Globe, supported by Hublot, showcasing incredible tenacity.",
            "id": "36a391aa-ee01-4696-a84c-afbc0eb0ee15",
            "is_major": true,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "The Vend\u00e9e Globe race, an unparalleled adventure, took place once again, this time marking a significant milestone on February 4, 2025. Swiss watch brand Hublot joined forces with sailor Alan Roura in this historic endeavor. The race involved circumnavigating the globe, covering approximately 24,000 nautical miles. The collaboration between Alan Roura and Hublot signifies their mutual aspiration to explore uncharted territories and surpass boundaries in the pursuit of excellence and innovation.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:33:00",
            "timestamp": "2025-02-04T12:33:00Z",
            "url": "https://www.prnewswire.com/news-releases/a-third-vendee-globe-for-alan-roura-hublot-celebrates-the-sailors-incredible-tenacity-302367443.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Kodiak Sciences to present at Glaucoma 360 New Horizons Forum 2025. Nasdaq: KOD, focusing on retinal disease therapeutics.",
            "id": "c75d2a47-0c32-4c97-94a2-66d10ecb7cdb",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "In Palo Alto, California, on February 4, 2025, Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical firm focused on researching, developing, and marketing innovative treatments for various retinal disorders, revealed that senior executives will...",
            "tickers": [
                "ALTO",
                "KOD",
                "NDXP"
            ],
            "time": "12:32:58",
            "timestamp": "2025-02-04T12:32:58Z",
            "url": "https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-glaucoma-360-new-horizons-forum-2025-302367078.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "ATI's Q4 2024 sales reach $1.2 billion, up 10% from Q4 2023. Full year 2024 sales hit $4.4 billion, 5% increase from 2023. Q4 2024 net income of $137 million.",
            "id": "c6750742-1383-49c8-bcde-d255185bbccb",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "In 2024, ATI reported its highest sales total since 2012, reaching $4.4 billion for the full year. In the fourth quarter alone, sales amounted to $1.2 billion, marking a 10% increase compared to Q4 of 2023. Overall, the full year 2024 sales saw a 5% rise from the previous year. The net income attributable to ATI in Q4 of 2024 was $137 million, equivalent to $0.94 per share.",
            "tickers": [
                "ATI"
            ],
            "time": "12:32:57",
            "timestamp": "2025-02-04T12:32:57Z",
            "url": "https://www.prnewswire.com/news-releases/ati-announces-fourth-quarter-2024-results-302366835.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Madison Square Garden Sports Corp. (NYSE: MSGS) reports fiscal 2025 Q2 results for Knicks and Rangers operations.",
            "id": "8d4f7763-a6b8-4047-8522-9c1997d06cb6",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "In a recent report released on February 4, 2025, Madison Square Garden Sports Corp. (NYSE: MSGS) shared its financial performance for the fiscal second quarter concluding on December 31, 2024. The second quarter of the fiscal year 2025 marked the commencement of activities for the New York Knicks (\"Knicks\") and New York Rangers (\"Rangers\").",
            "tickers": [
                "NDXP",
                "MSGS"
            ],
            "time": "12:32:55",
            "timestamp": "2025-02-04T12:32:55Z",
            "url": "https://www.prnewswire.com/news-releases/madison-square-garden-sports-corp-reports-fiscal-2025-second-quarter-results-302366911.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Quoin Pharmaceuticals starts 'NETHERTON NOW' campaign to raise awareness of Netherton Syndrome, a rare genetic disease with no cure. Up to 20% of babies born with this condition do not survive.",
            "id": "9a85043c-1fcb-4894-9dfb-627552e46e15",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) based in Ashburn, Virginia, announced on February 4, 2025, the launch of the \u201cNETHERTON NOW\u201d campaign. This initiative aims to raise awareness about Netherton Syndrome, a rare genetic disease. The campaign seeks to address the lack of understanding surrounding the severe impacts of the condition which has previously led to misdiagnoses. Netherton Syndrome has a high mortality rate, with approximately 20% of infants born with the disease not surviving. This underscores the critical necessity for enhanced awareness and the development of novel treatment approaches to combat the challenges associated with this disorder.",
            "tickers": [
                "NDXP",
                "QNRX"
            ],
            "time": "12:32:53",
            "timestamp": "2025-02-04T12:32:53Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020192/0/en/Quoin-Pharmaceuticals-Launches-NETHERTON-NOW-Campaign-to-Raise-Awareness-of-Netherton-Syndrome-a-Rare-Genetic-Disease-with-No-Approved-Treatment-or-Cure.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "PSEG to share Q4 and full year 2024 financial results on Feb 25. Earnings call at 11:00 am ET.",
            "id": "e6963557-a2ca-4459-92b3-4cfabdf3919f",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "On February 4, 2025, in Newark, New Jersey, Public Service Enterprise Group Incorporated (PSEG) announced that they will conduct an earnings call for the fourth quarter and full year of 2024 at 11:00 a.m. ET on February 25. The call will involve discussions by management regarding the financial outcomes for the fourth quarter and the full year.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:53",
            "timestamp": "2025-02-04T12:32:53Z",
            "url": "https://www.prnewswire.com/news-releases/pseg-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-february-25-302366757.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Pyxis Oncology starts PYX-201 combo trial with Merck's KEYTRUDA\u00ae, targeting EDB+FN, in solid tumors. Phase 1/2 trial initiated.",
            "id": "a7a00569-c6a2-43e0-af1e-188cfd2bc275",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Commencement of a Phase 1/2 joint trial involving PYX-201, an extracellular ADC focusing on Extradomain-B Fibronectin (EDB+FN), and Merck\u2019s KEYTRUDA\u00ae (pembrolizumab) in various solid tumors.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:52",
            "timestamp": "2025-02-04T12:32:52Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020191/0/en/Pyxis-Oncology-Initiates-New-PYX-201-Combination-Trial-and-Initiates-Cohort-Expansions-of-Ongoing-Monotherapy-Trial.html"
        },
        {
            "beta_headline": null,
            "category": "crypto",
            "date": "2025-02-04",
            "headline": "CME Group reports record January average daily volume of 25.7 million contracts, with highs in energy, agriculture, and crypto products.",
            "id": "a2e6c7ca-35be-4e45-98c1-19be27d83678",
            "is_major": true,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "In January 2025, CME Group, a top derivatives marketplace, announced record high average daily volumes (ADV) for energy, agricultural, and cryptocurrency products. Additionally, there was a record high ADV in U.S. Treasury futures and options. The specific ADV figure for the month was not disclosed in the provided information.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:51",
            "timestamp": "2025-02-04T12:32:51Z",
            "url": "https://www.prnewswire.com/news-releases/cme-group-reports-record-january-adv-of-25-7-million-contracts-302367053.html"
        },
        {
            "beta_headline": null,
            "category": "commodities",
            "date": "2025-02-04",
            "headline": "Red Pine drilling at Wawa Gold Project shows expansion of gold system with visible gold found 170m and 100m apart.",
            "id": "d1624c48-c560-4477-aeed-3f9b99918204",
            "is_major": true,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "There were three drill holes conducted to test the depth extensions of the Jubilee Shear. These drill holes revealed the presence of quartz veins containing visible gold, located about 170 m and 100 m from the original site.",
            "tickers": [],
            "time": "12:32:50",
            "timestamp": "2025-02-04T12:32:50Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020186/0/en/Red-Pine-Drilling-Expands-Gold-System-at-Wawa-Gold-Project.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "XOMA Royalty to attend Oppenheimer 35th Annual Healthcare Life Sciences Conference on Feb 11-12, 2025. ",
            "id": "e75846cb-0392-4626-93f7-76483258cb98",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "In Emeryville, California, on February 4, 2025, XOMA Royalty Corporation revealed representatives from its Executive Team are set to take part in the Oppenheimer 35th Annual Healthcare Life Sciences Conference taking place online on February 11-12, 2025. XOMA Royalty Corporation is listed on NASDAQ as XOMA.",
            "tickers": [
                "NDXP",
                "XOMA"
            ],
            "time": "12:32:49",
            "timestamp": "2025-02-04T12:32:49Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020181/7281/en/XOMA-Royalty-to-Present-at-Oppenheimer-35th-Annual-Healthcare-Life-Sciences-Conference.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Soligenix announced its participation in BIO CEO & Investor Conference, Feb 4, 2025. (Nasdaq: SNGX) $SNGX.",
            "id": "dddb5ba6-5d2c-433b-b125-2117a186cead",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Soligenix, Inc., a biopharmaceutical company based in Princeton, New Jersey, disclosed on February 4, 2025, its focus on developing and marketing treatments for rare diseases with unmet medical requirements. Traded under the Nasdaq symbol SNGX, the Company disclosed the latest news without specifying the details.",
            "tickers": [
                "BIO",
                "SNGX",
                "NDXP"
            ],
            "time": "12:32:49",
            "timestamp": "2025-02-04T12:32:49Z",
            "url": "https://www.prnewswire.com/news-releases/soligenix-to-present-at-bio-ceo--investor-conference-302367353.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "I-Mab participating in Oppenheimer's 35th Annual Healthcare Conference on Feb. 11-12, 2025.NASDAQ: IMAB, global biotech company.",
            "id": "5613d241-7fe9-48a6-b648-379797f7097f",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "On February 4, 2025, in Rockville, Maryland, I-Mab (NASDAQ: IMAB), a global biotech company headquartered in the U.S., specializing in precision immuno-oncology treatments for cancer, disclosed its participation in Oppenheimer\u2019s 35th Annual Healthcare Life Sciences Conference. The event, occurring online on February 11-12, 2025, will feature I-Mab\u2019s management team.",
            "tickers": [
                "IMAB",
                "NDXP"
            ],
            "time": "12:32:47",
            "timestamp": "2025-02-04T12:32:47Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020180/0/en/I-Mab-to-Present-at-Oppenheimer-s-35th-Annual-Healthcare-Life-Sciences-Conference.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Data center switch sales in AI back-end networks to surpass $100 billion in 5 years. Celestica, Huawei, and NVIDIA led in 2024. Market shifts projected in 2025.",
            "id": "ff545f97-5573-41a2-ad48-89dc0baebc76",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Leading the market in 2024 were Celestica, Huawei, and NVIDIA as per the AI Networks for AI Workloads report by Dell'Oro Group. This report was published on February 4, 2025, in REDWOOD CITY, Calif. The report highlighted the dominant position of these companies in the market. However, potential major market shifts are anticipated in 2025, indicating a dynamic landscape in the coming year. This information signifies the evolving nature of the industry and the competitive environment within it.",
            "tickers": [
                "NVDA",
                "NDXP"
            ],
            "time": "12:32:47",
            "timestamp": "2025-02-04T12:32:47Z",
            "url": "https://www.prnewswire.com/news-releases/data-center-switch-sales-in-ai-back-end-networks-to-exceed-100-b-over-the-next-five-years-according-to-delloro-group-302367070.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Cumberland Pharmaceuticals reports positive results from Phase 2 FIGHT DMD trial in Duchenne Muscular Dystrophy Heart Disease. $CPIX.",
            "id": "692ad4e7-10a7-48d6-924a-ef73f9d58ac0",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Nashville, Tennessee - On February 4, 2025, Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialized pharmaceutical company concentrating on developing new products for rare diseases, shared that their Phase 2 FIGHT DMD trial has yielded encouraging top-line outcomes. The study...",
            "tickers": [
                "NDXP",
                "CPIX"
            ],
            "time": "12:32:45",
            "timestamp": "2025-02-04T12:32:45Z",
            "url": "https://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-announces-breakthrough-results-from-the-phase-2-fight-dmd-trial-in-duchenne-muscular-dystrophy-heart-disease-302367014.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Bread Financial (NYSE: BFH) to attend BofA Securities 2025 Financial Services Conference on Feb. 11 in Ohio.",
            "id": "65bb3215-44f9-4e51-bfcc-fd783ef00e4f",
            "is_major": true,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "A tech-driven financial services company, Bread Financial\u00ae Holdings, Inc. (NYSE: BFH), based in Columbus, Ohio, revealed its involvement in the BofA Securities 2025 Financial Services Conference scheduled for Tuesday, Feb. 11. Bread Financial\u00ae offers tailored payment, lending, and saving options to a vast number of American consumers. The company aims to provide straightforward and individualized financial solutions to millions of customers across the United States.",
            "tickers": [
                "NDXP",
                "BFH"
            ],
            "time": "12:32:45",
            "timestamp": "2025-02-04T12:32:45Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020176/0/en/Bread-Financial-to-Participate-in-the-BofA-Securities-2025-Financial-Services-Conference.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global Crossing Airlines expects to report Q4 and full year 2024 financial results at high end of guidance. Company is Nation's fastest growing charter airline, trading under symbols JET, JET.B, JETMF. Operations update provided.",
            "id": "c8fc60f6-011f-427a-a969-34366d324e27",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Miami-based Global Crossing Airlines Group, Inc. (ticker symbols: Cboe CA: JET, Cboe CA: JET.B, OTCQB: JETMF), known as GlobalX, stated on February 4, 2025, that they anticipate their fourth quarter and full-year financials to exceed the projections set for 2024. This fastest-growing charter airline in the country also shared some recent operational highlights.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:43",
            "timestamp": "2025-02-04T12:32:43Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020174/0/en/Global-Crossing-Airlines-to-Achieve-High-End-of-its-Fourth-Quarter-Full-Year-2024-Guidance-Provides-Operational-Updates.html"
        },
        {
            "beta_headline": null,
            "category": "crypto",
            "date": "2025-02-04",
            "headline": "DeFi Technologies secures $20M CORE token commitment for Bitcoin finance, plans reverse takeover on Cboe Canada Stock Exchange.",
            "id": "e5ed8939-fe52-4739-a606-62b75b514e65",
            "is_major": true,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "DeFi Technologies has struck a strategic partnership and reverse takeover deal with CoreFi Strategy and Orinswift Ventures. This agreement will lead to the listing of the new entity's common shares on the Cboe Canada Stock Exchange (Cboe). The collaboration involves a binding letter agreement and aims to leverage the strengths of all parties involved. This move is part of a larger strategy to expand DeFi Technologies' presence in the market and broaden its shareholder base. The specific financial details of the deal, including the numbers involved, have not been disclosed publicly yet.",
            "tickers": [],
            "time": "12:32:43",
            "timestamp": "2025-02-04T12:32:43Z",
            "url": "https://www.prnewswire.com/news-releases/defi-technologies-signs-binding-loi-with-corefi-strategy-and-orinswift-ventures-secures-us20m-core-token-commitment-from-the-core-foundation-to-drive-bitcoin-finance-302367182.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "DURECT CEO to present at Oppenheimer Conference on Feb 11-12, 2025. ",
            "id": "aac40ff4-37df-4a57-8dd7-f02e419a24eb",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "On February 4, 2025, in Cupertino, California, DURECT Corporation (Nasdaq: DRRX) shared news of James E. Brown, the President and CEO, set to present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11-12, 2025, conducted virtually.",
            "tickers": [
                "DRRX",
                "NDXP"
            ],
            "time": "12:32:39",
            "timestamp": "2025-02-04T12:32:39Z",
            "url": "https://www.prnewswire.com/news-releases/durect-corporation-to-present-at-oppenheimer-35th-annual-healthcare-life-sciences-conference-302366991.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Applied Materials recognizes suppliers for outstanding performance, giving Supplier Excellence Awards to those who excelled in quality, service, and delivery.",
            "id": "1fdc4b95-0303-4cf1-98e9-c6f51c080405",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Today, in Santa Clara, California, Applied Materials, Inc. revealed the winners of the Supplier Excellence Awards for their noteworthy contributions to the company's operations in the previous year. These accolades recognize exceptional performance in key areas such as quality, service, sustainability, delivery time, cost-effectiveness, and responsiveness. The recipients were honored for their outstanding technical and operational achievements, demonstrating their commitment to excellence in supporting Applied Materials, Inc. throughout the year.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:38",
            "timestamp": "2025-02-04T12:32:38Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020193/0/en/Applied-Materials-Awards-Suppliers-for-Outstanding-Performance.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global oral solid dosage contract manufacturing market expected to reach US$40,776.0 million by 2034. US FDA-approved facilities key driver. India & China lead market. Constraints include capacity limitations. North America, Asia Pacific driving industry growth.",
            "id": "a61f7ce1-dd99-4513-8ad5-8cacc2f0cd11",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The global oral solid dosage contract manufacturing market is projected to reach US$26,457.9 million in 2024, with a CAGR of 4.4% expected from 2024 to 2034, reaching US$40,776.0 million by 2034. The growth is driven by the increasing number of US FDA-approved manufacturing facilities, with India and China dominating the market. India, with 400 FDA-recognized facilities, is a popular outsourcing destination for oral solid dosage contract manufacturing. Other countries like China, Mexico, and Brazil also have approved facilities. However, capacity limitations due to small and mid-sized facilities, scarcity of skilled workers, and limitations in production processes are hindrances to market growth. North America leads in the industry due to pharmaceutical excellence, while Asia Pacific is emerging as a major hub for oral solid dosage contract manufacturing due to increasing research and development investments.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:11",
            "timestamp": "2025-02-04T12:32:11Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43459094/oral-solid-dosage-contract-manufacturing-market-is-expected-to-reach-a-valuation-of-us-40-776-0-mi"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global nocturia market valued at US$3.7 billion in 2023. Projected to reach US$8.5 billion by 2034, growing at 8.0% CAGR. Aging population and chronic diseases driving growth. Key players include AbbVie Inc., Astellas Pharma Inc., Pfizer, among others. Market booming with innovations in treatment options. Rising awareness leading to increased focus on urinary health. Medical advancements addressing unmet patient needs.",
            "id": "51977b6e-5005-492c-85fe-80f51b6147c5",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The global nocturia market, valued at US$3.7 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 8.0%, reaching US$8.5 billion by 2034. Nocturia, characterized by frequent nighttime urination, is on the rise due to factors like an aging population, increasing incidences of chronic diseases, and raised awareness of urinary health. Key players driving this market growth include AbbVie Inc., Astellas Pharma Inc., and Pfizer, with recent developments focusing on new formulations and collaborations for AI-based diagnostic tools. The market is expanding due to the prevalence of conditions like diabetes and hypertension, particularly in developed regions, and is supported by advancements in diagnostic tools and therapeutic options. Rising awareness and investments in research and development are driving the growth of the market, with a focus on improving patient outcomes and quality of life.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:32:07",
            "timestamp": "2025-02-04T12:32:07Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43459102/aging-population-fuels-nocturia-market-growth-projected-to-reach-us-8-5-billion-by-2034-latest-res"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Tornado Infrastructure Equipment launches Tornado Equipment Finance, offering financing solutions for customers in Canada.",
            "id": "169e7030-7aaf-4b93-926b-941806596a23",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Calgary, Alberta - Tornado Infrastructure Equipment Ltd. has introduced Tornado Equipment Finance Ltd., aimed at offering financing, rental, and leasing services to assist customers with equipment requirements throughout Canada. The company, listed as TGH on TSX-V and TGHLF on OTCQX, is expanding its services to cater to a growing market. This strategic move is set to benefit customers seeking financial support for equipment solutions.",
            "tickers": [
                "NDXP",
                "TGH"
            ],
            "time": "12:31:36",
            "timestamp": "2025-02-04T12:31:36Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020184/0/en/Tornado-Infrastructure-Equipment-Launches-Tornado-Equipment-Finance-Provides-Q4-2024-Business-Update-and-Implements-Tariff-Mitigation-Strategies.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "AYR Wellness (CSE: AYR.A, OTCQX: AYRWF) to hold Q4 & full year 2024 conference call on March 6 at 8:30 a.m. ET.",
            "id": "a1505c02-2bb9-4494-ac2b-36cf98e9859c",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "On February 4, 2025, AYR Wellness Inc. announced a conference call scheduled for March 6, 2025, at 8:30 a.m. ET to review their financial performance for the fourth quarter and full year ending December 31, 2024. AYR, a prominent U.S. cannabis operator with listings on the CSE under AYR.A and OTCQX as AYRWF, will host the call to discuss their results.",
            "tickers": [
                "NDXP",
                "AYR"
            ],
            "time": "12:31:34",
            "timestamp": "2025-02-04T12:31:34Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020183/0/en/AYR-Wellness-to-Hold-Fourth-Quarter-and-Full-Year-2024-Conference-Call-on-March-6-at-8-30-a-m-ET.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Sensei Biotherapeutics (Nasdaq: SNSE) to present at Oppenheimer's Healthcare Life Sciences Conference on Feb 11, 2025 at 10:40am ET.",
            "id": "51ce7997-d316-4898-9bd5-5e211529834a",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "Boston-based biotechnology company, Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), is set to participate in Oppenheimer\u2019s 35th Annual Healthcare Life Sciences Conference. CEO John Celebi will present virtually on February 11, 2025 at 10:40 a.m. ET. Sensei focuses on developing advanced treatments for cancer patients and is currently in the clinical stage of research.",
            "tickers": [
                "SNSE",
                "NDXP"
            ],
            "time": "12:31:32",
            "timestamp": "2025-02-04T12:31:32Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020177/0/en/Sensei-Biotherapeutics-to-Participate-in-Oppenheimer-s-35th-Annual-Healthcare-Life-Sciences-Conference.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "ADM reported $1.8 billion in net earnings and adjusted net earnings of $2.3 billion for full year 2024, with earnings per share of $3.65 and adjusted earnings per share of $4.74. Trailing four-quarter average return on invested capital was 6.7%.",
            "id": "72045f39-5444-4fea-911a-0bd0a281a196",
            "is_major": true,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "In Chicago, ADM disclosed its financial performance for the fourth quarter and full year ending on December 31, 2024. The company reported a net earnings figure of $1.8 billion for the full year, with adjusted net earnings standing at $2.3 billion. Earnings per share for the period were reported at $3.65, while adjusted earnings per share was $4.74, showing a decline compared to the previous year. Moreover, the trailing four-quarter average return on invested capital (ROIC) was calculated at 6.7%, with the adjusted ROIC at 8.3% for the same period.",
            "tickers": [
                "NDXP",
                "ADM"
            ],
            "time": "12:31:16",
            "timestamp": "2025-02-04T12:31:16Z",
            "url": "http://www.businesswire.com/news/home/20250204109464/en/ADM-Reports-Fourth-Quarter-and-Full-Year-2024-Results-Provides-2025-Guidance/?feedref=JjAwJuNHiystnCoBq_hl-YKT6SDyMw5Lye4ovXwHmkqD8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5idAXrgr_e1ZUbxvK6BY66Xm"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Hubbell, based in Shelton, CT, reported their Q4 2024 and full year results on Feb. 04, 2025. No specific numbers were mentioned.",
            "id": "1af0ccfb-4d27-4095-bf8d-922022342ea8",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": "In Shelton, CT on February 4, 2025, leading company Hubbell released their financial results for the fourth quarter of 2024 and the full year. The report covered revenue, profit, and other key financial indicators for the company. This data provides valuable insights into Hubbell's performance over the specified period, highlighting their growth, challenges, and achievements. This information is crucial for investors, analysts, and stakeholders looking to assess the company's financial health and future prospects.",
            "tickers": [
                "HUBB",
                "NDXP"
            ],
            "time": "12:30:50",
            "timestamp": "2025-02-04T12:30:50Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020182/0/en/Hubbell-Reports-Fourth-Quarter-2024-and-Full-Year-Results.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Mize acquires RightRez to innovate air travel solutions, strengthening its market presence.",
            "id": "75aac16a-44a0-4e28-978a-e6b1aa2fdaa1",
            "is_major": true,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Israeli company Mize has recently acquired RightRez, a company specializing in air automation and post-booking optimization solutions. The acquisition, announced on February 4, 2025, solidifies Mize's position in the travel industry. This move signifies Mize's strategic expansion in the sector, combining their fintech solutions with RightRez's expertise. The deal represents a significant development in the industry, with the specific financial figures remaining undisclosed.",
            "tickers": [
                "TEL",
                "AVIV",
                "NDXP"
            ],
            "time": "12:30:37",
            "timestamp": "2025-02-04T12:30:37Z",
            "url": "https://www.prnewswire.com/news-releases/mize-expands-its-horizons-acquires-rightrez-to-revolutionize-air-travel-solutions-302367440.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Laser Photonics Corp. (NASDAQ: LASE) and subsidiary, CMS Laser, to expand tech program for Wafer Marking with precision.",
            "id": "d1f91196-8bac-4828-8ab1-445fa8174c9a",
            "is_major": false,
            "source": "Business Wire",
            "source_type": "news",
            "summary": "Laser Photonics Corporation (NASDAQ: LASE) and its subsidiary, Control Micro Systems, Inc. (CMS Laser), have revealed the enlargement of their Laser Wafer Marking technology research program. This program focuses on creating precise laser systems to engrave serial numbers and vital data on materials. These technologies are crucial for industries requiring accurate marking processes. The development aims to enhance efficiency and innovation in industrial laser systems.",
            "tickers": [
                "NDXP",
                "LASE"
            ],
            "time": "12:30:33",
            "timestamp": "2025-02-04T12:30:33Z",
            "url": "http://www.businesswire.com/news/home/20250204370429/en/Laser-Photonics-Propels-RD-Efforts-in-Wafer-Marking/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ=="
        },
        {
            "beta_headline": null,
            "category": "commodities",
            "date": "2025-02-04",
            "headline": "Global circuit breakers market to hit $23 billion by 2033, with a 6.9% CAGR. Growth driven by urbanization, industrialization, and renewable energy projects. Opportunities in smart circuit development.",
            "id": "baf45c7f-e62d-4df5-91d8-c2ac21548fa0",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The article discusses a report by Allied Market Research on the \"Circuit Breakers Market,\" indicating that it was valued at $11.9 billion in 2023 and is projected to reach $23 billion by 2033, with a CAGR of 6.9% from 2024 to 2033. The market growth is driven by the rising demand for secure power supply, urbanization, industrialization, and investments in renewable energy projects. There are challenges like high initial costs and outdated infrastructure, but opportunities lie in smart circuit breaker development, IoT technologies, and electrification in emerging economies. The report covers details such as forecast period of 2024-2033, 466 pages, segments on type, product type, voltage, insulation type, installation, end user, and region.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:27:02",
            "timestamp": "2025-02-04T12:27:02Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43458912/circuit-breakers-market-to-reach-23-billion-globally-by-2033-at-6-9-cagr-allied-market-research"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global thermal batteries for military market to grow at 6.4% CAGR, reaching $274.2 million by 2033 from $149.1 million in 2023.",
            "id": "99920636-70cb-4337-ba3b-6f0a5937263c",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The Allied Market Research report on \"Thermal Batteries for Military Market\" states that the market was valued at $149.1 million in 2023 and is projected to reach $274.2 million by 2033, with a compound annual growth rate (CAGR) of 6.4% from 2024 to 2033. Factors contributing to this growth include increasing demand for lightweight energy solutions in defense, investments in defense infrastructure, and advancements in thermal battery technology. Challenges like performance limitations under extreme conditions exist, but innovations in manufacturing and materials have lowered production costs, increasing accessibility for military use. Additionally, the adoption of sustainable and eco-friendly materials addresses environmental concerns and aligns with the military's shift towards greener practices without compromising performance. The full article can be accessed on Benzinga.com.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:26:59",
            "timestamp": "2025-02-04T12:26:59Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43458931/thermal-batteries-for-military-market-to-reach-274-2-million-globally-by-2033-at-6-4-cagr-allied-m"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Hamilton Lane's Q3 fiscal 2025 results show 11% growth in management & advisory fees, assets under management up by 12%. Total AUM at $134.7B, fee-earning AUM at $71.0B. Management and advisory fees at $126.3M. Unrealized carried interest balance at about $1.3B. GAAP EPS at $1.32. Quarterly dividend declared at $0.49 per share of Class A common stock. Target full-year dividend increased by 10% from the prior fiscal year. Conference call scheduled for February 4, 2025.",
            "id": "3ed917ab-6d30-40a7-abce-37e5debe9382",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "Private markets asset management firm Hamilton Lane Incorporated reported its third fiscal quarter results, ending on December 31, 2024. Key figures include total assets under management reaching $134.7 billion, growing by $14.8 billion year-over-year. Fee-earning assets under management also increased by $7.9 billion to $71.0 billion. Revenue from management and advisory fees saw 11% growth, amounting to $126.3 million for the quarter. The unrealized carried interest balance was around $1.3 billion, up by 15% compared to the prior year. Earnings per share stood at $1.32 with $53.0 million in GAAP net income. A quarterly dividend of $0.49 per share was declared for Class A common stock, with a target full-year dividend of $1.96, signifying a 10% increase from the prior fiscal year. For more detailed information, a presentation of the results is available on the Company's Shareholders' website. The firm will discuss these results in a conference call on February 4, 2025.",
            "tickers": [
                "HLNE",
                "NDXP"
            ],
            "time": "12:25:56",
            "timestamp": "2025-02-04T12:25:56Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/n43458143/hamilton-lane-incorporated-reports-third-quarter-fiscal-2025-results-with-management-advisory-fees"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "BetMGM expects positive EBITDA in 2025 with Net Revenue of $2.4-2.5 billion. They aim for $500 million EBITDA in the future.",
            "id": "3928cfb9-4dce-4d60-8a50-40257f1f296a",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "BetMGM, a major sports betting and iGaming operator, provided an update on its FY 2024 performance. The company saw growth in iGaming and sports products, with FY 2025 expected to be EBITDA positive and a net revenue of $2.4-$2.5 billion. CEO Adam Greenblatt expressed confidence in achieving $500 million EBITDA in the future. Key financial highlights for 2024 included $1.479 million in iGaming net revenue (13% YoY increase), $554 million in online sports net revenue (4% YoY increase), and a total net revenue of $2.102 million (7% YoY increase). These figures indicate a positive trend for the company's financial performance.",
            "tickers": [
                "MGM",
                "GMVHY",
                "NDXP",
                "ENT"
            ],
            "time": "12:25:54",
            "timestamp": "2025-02-04T12:25:54Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/n43458146/betmgm-fy-2024-update"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "PayPal releases Q4 and full year 2024 results at https://investor.pypl.com. For full story, visit Benzinga.com.",
            "id": "c8b10a6b-182d-45d8-9d4a-09d795d3d411",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "In San Jose, California, on February 4, 2025, PayPal Holdings, Inc. (NASDAQ: PYPL) revealed its financial performance for the fourth quarter and full year of 2024 until December 31, 2024. The details of the earnings report and other relevant materials pertaining to these outcomes are now accessible on PayPal's investor relations portal: https://investor.pypl.com/financials/quarterly-results/default.aspx. PayPal Holdings, Inc. will also conduct a meeting ... (Continue reading on Benzinga.com)",
            "tickers": [
                "PYPL",
                "NDXP"
            ],
            "time": "12:25:52",
            "timestamp": "2025-02-04T12:25:52Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/n43458162/paypal-reports-fourth-quarter-and-full-year-2024-results"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Humantic AI named Cool Vendor in 2024 Gartner report for AI-led Sales. Helps sellers with buyer-first approach. PALO ALTO, Feb 4, 2025 /PRNewswire.",
            "id": "93e45b23-9e47-4d76-a178-cab66956a541",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Humantic AI, based in Palo Alto, California, is aiding enterprise sellers in shifting towards a buyer-centric strategy. The AI tool assists sellers in prepping for meetings, tailoring calls, and crafting impactful emails to strengthen connections with buyers. This innovative approach is designed to cultivate long-term relationships and drive sales success. The news was released on February 4, 2025, marking a significant step forward in revolutionizing sales practices.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:24:34",
            "timestamp": "2025-02-04T12:24:34Z",
            "url": "https://www.prnewswire.com/news-releases/humantic-ai-recognized-as-a-cool-vendor-in-the-2024-gartner-cool-vendors-in-ai-led-sales-research-302367434.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "The CLARITY Trial for Nociscan is fully funded, announced by Aclarion.",
            "id": "26dcf02f-3295-400f-bed4-bb6c3cadbb73",
            "is_major": false,
            "source": "GlobeNewswire",
            "source_type": "news",
            "summary": null,
            "tickers": [],
            "time": "12:24:30",
            "timestamp": "2025-02-04T12:24:30Z",
            "url": "https://www.globenewswire.com/news-release/2025/02/04/3020172/0/en/Aclarion-Announces-CLARITY-Trial-for-Nociscan-Now-Fully-Funded.html"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Xi's strategic response to Trump's tariffs shows China's greater vulnerability amid trade tensions.",
            "id": "5cf30e49-f3c9-496e-a732-292ff0ef02a9",
            "is_major": false,
            "source": "Bloomberg",
            "source_type": "news",
            "summary": null,
            "tickers": [
                "NDXP"
            ],
            "time": "12:24:22",
            "timestamp": "2025-02-04T12:24:22Z",
            "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPX2dxaWtpS0VsZU9OTVI4MkpfZ2FrNXFuOGVtbzZpSC12cm96dmdtcUxtSnNMQU0ybXlJX0VsamVNTEFmMzNRSWJDdkJUQkFwWndseEUzd2liSjdRYkoxeVBjOE9pcExPOTN2enE0SXN2alNrM2pLejlGSlIyUkE5V2FfOGJBbzZTSlI4ZXZ1WkIwenZkMGRPS2dkcDNhaEVUQU1YQlFFclUzM0Jpd0ZLWi1GNGFjdw?oc=5"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global fractional flow reserve market valued at $901.3 million in 2023, projected to reach $2,558.34 million by 2035 at 9.1% CAGR.",
            "id": "6fc9ac44-0f2d-4b74-9057-5086bb922e5d",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The \"Fractional Flow Reserve Market\" was valued at $901.3 million in 2023 and is expected to reach $2,558.34 million by 2035, growing at a CAGR of 9.1% from 2024 to 2035. Key factors driving this growth include the rise in cardiovascular diseases, favorable reimbursement policies, guidelines for FFR, and demand for minimally invasive procedures. However, high costs restrict market growth. There is potential growth in emerging countries and advancements in FFR technology offer new opportunities.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:21:54",
            "timestamp": "2025-02-04T12:21:54Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43458790/fractional-flow-reserve-market-to-reach-2-558-34-million-globally-by-2035-at-9-1-cagr-allied-marke"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Global clot management devices market to reach $4.3B by 2035, growing at 6.2% CAGR from $2.1B in 2023. ",
            "id": "58f2e29d-8834-43a0-838a-623bc6d4fc36",
            "is_major": false,
            "source": "Benzinga",
            "source_type": "news",
            "summary": "The report by Allied Market Research focuses on the Clot Management Devices Market, stating that it was valued at $2.1 billion in 2023 and is projected to reach $4.3 billion by 2035, with a growth rate (CAGR) of 6.2% from 2024 to 2035. The key drivers for this growth are the increasing prevalence of thromboembolic disorders and the rising trend towards minimally invasive surgeries. However, the market is hindered by the high costs associated with these devices and procedures. Nevertheless, technological advancements are expected to provide growth opportunities in the forecast period.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:21:52",
            "timestamp": "2025-02-04T12:21:52Z",
            "url": "https://www.benzinga.com/pressreleases/25/02/g43458900/clot-management-devices-market-to-reach-4-3-billion-globally-by-2035-at-6-2-cagr-allied-market-res"
        },
        {
            "beta_headline": null,
            "category": "news",
            "date": "2025-02-04",
            "headline": "Merck's stock drops by 6% after quarterly beat but soft guidance concerns investors.",
            "id": "93d1d25b-3600-4426-be69-1ef930e2d67e",
            "is_major": false,
            "source": "Market Watch",
            "source_type": "news",
            "summary": null,
            "tickers": [],
            "time": "12:21:01",
            "timestamp": "2025-02-04T12:21:01Z",
            "url": "https://www.marketwatch.com/bulletins/redirect/go?g=be7d200b-561b-4606-8ffe-a839a4d53eb7&mod=mw_rss_bulletins"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "KKR raises long-term private equity earnings forecast.",
            "id": "ae06d2c8-60f0-44cc-b1f2-e2cee674130a",
            "is_major": true,
            "source": "Bloomberg",
            "source_type": "news",
            "summary": null,
            "tickers": [
                "KKR",
                "NDXP"
            ],
            "time": "12:20:20",
            "timestamp": "2025-02-04T12:20:20Z",
            "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNek9sYVh2aEtqQTN0cWhucnpxd1BlOEdHMDNtYXRMeElBYkNPNkdQSnhTb3JRTlVEQkxweWI2UlNzUGFoT0ZXUDhLNEdiOEJLM1N4NVgyeU5pY0QtSVlNeERqNUE1TEdVYlZneEkzTWxnWEV6akNnN2lVQy1YQ2E2NWh5UnJUX01za09vTEhkWFVWbENQTnFuOV8xcGNnNGZFMDkyMGVjQ05DbmxkWkJMMEJYTQ?oc=5"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Spotify beats estimates for subscribers and users in Q4, stock jumps. Users flocking to music streamer.",
            "id": "3b065e47-850c-4069-ab02-e585f9347c26",
            "is_major": false,
            "source": "Investors.com",
            "source_type": "news",
            "summary": "In the fourth quarter, Spotify Technology exceeded analyst expectations for both subscribers and users, leading to a surge in Spotify stock. More individuals are gravitating towards the music streaming platform, resulting in a positive impact on the company's performance.",
            "tickers": [],
            "time": "12:20:08",
            "timestamp": "2025-02-04T12:20:08Z",
            "url": "https://www.investors.com/news/technology/spotify-stock-spot-q4-2024-earnings/"
        },
        {
            "beta_headline": null,
            "category": "crypto",
            "date": "2025-02-04",
            "headline": "Bitcoin has surged by 160% post the Ethereum Merge while ETH supply rises, whales dump, and Solana gains as a rival.",
            "id": "9d0af8a4-1789-4e40-8e1d-39103d8ee12d",
            "is_major": false,
            "source": "Cointelegraph",
            "source_type": "news",
            "summary": "The supply of Ethereum is increasing, with large holders of ETH selling off their holdings, while Solana, its main competitor, is making strides in the market over two years after transitioning to a proof-of-stake system.",
            "tickers": [
                "ETH"
            ],
            "time": "12:20:02",
            "timestamp": "2025-02-04T12:20:02Z",
            "url": "https://cointelegraph.com/news/worst-thing-ethereum-eth-price-down-70-btc-the-merge?utm_source=rss_feed&utm_medium=rss&utm_campaign=rss_partner_inbound"
        },
        {
            "beta_headline": null,
            "category": "securities",
            "date": "2025-02-04",
            "headline": "Mill Creek reveals first retail tenants at Modera Falls Church: Tatte Bakery & Caf\u00e9 and MyHome Thai Bistro to join community.",
            "id": "34433ac8-ce5c-468f-b2c1-97999a9fd64c",
            "is_major": false,
            "source": "PR NewsWire",
            "source_type": "news",
            "summary": "Two popular eateries, Tatte Bakery & Caf\u00e9 and MyHome Thai Bistro, have been confirmed to become part of a modern mixed-use community in FALLS CHURCH, Va. On February 4, 2025, Mill Creek Residential, a prominent developer, owner-operator, and investment manager in premier rental housing throughout the U.S., revealed this news. This development marks another step forward for the community, with both establishments contributing to the diverse culinary options available.",
            "tickers": [
                "NDXP"
            ],
            "time": "12:18:32",
            "timestamp": "2025-02-04T12:18:32Z",
            "url": "https://www.prnewswire.com/news-releases/mill-creek-announces-initial-retail-tenants-at-modera-falls-church-302367337.html"
        }
    ]
}
